Tamer M Sakr

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

Pharmaceuticals (Basel, Switzerland)

Pharmaceutics

Molecules (Basel, Switzerland)

October University for Modern Sciences and Arts Faculty of Pharmacy

Ain Shams University Faculty of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

October University for Modern Sciences and Arts Faculty of Pharmacy

Egypt

Associate Professor of Pharmaceutical chemistryProfessor of Pharmaceutical chemistry :: Pharmaceutical Chemistry

Egyptian Atomic Energy Authority

Egypt

Associate Professor of radiopharmaceutical chemistry :: Radioactive isotopes and generator department

Egyptian Atomic Energy Authority

Egypt

Assistant professor of radiopharmaceutical chemistry :: Radioactive isotopes and generators department

Egyptian Atomic Energy Authority

Egypt

Assistant lecturer of radiopharmaceutical chemistry :: Radioactive isotopes and generator department

Egyptian Atomic Energy Authority

Egypt

Radiopharmacist :: Radioactive isotopes and generator department

Education History

Ain Shams University Faculty of Pharmacy

Egypt

PHD :: Pharmaceutical chemistry

Helwan University Faculty of Pharmacy

Egypt

BSC

Publications

Rana M El-Masry, Basma M Essa, Adli Abdallah Selim, Soad Z El-Emam, Khaled O Mohamed, Tamer M Sakr, Hanan H Kadry, Azza T Taher, Sahar M Abou-Seri
New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Rana M El-Masry, Basma M Essa, Adli Abdallah Selim, Soad Z El-Emam, Khaled O Mohamed, Tamer M Sakr, Hanan H Kadry, Azza T Taher, Sahar M Abou-Seri
New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Rana M El-Masry, Basma M Essa, Adli Abdallah Selim, Soad Z El-Emam, Khaled O Mohamed, Tamer M Sakr, Hanan H Kadry, Azza T Taher, Sahar M Abou-Seri
New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Rana M El-Masry, Basma M Essa, Adli Abdallah Selim, Soad Z El-Emam, Khaled O Mohamed, Tamer M Sakr, Hanan H Kadry, Azza T Taher, Sahar M Abou-Seri
New 5-Aryl-1,3,4-Thiadiazole-Based Anticancer Agents: Design, Synthesis, In Vitro Biological Evaluation and In Vivo Radioactive Tracing Studies. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Amir R Jalilian, Blanca Ocampo-Garcia, Wanvimol Pasanphan, Tamer M Sakr, Laura Melendez-Alafort, Mariano Grasselli, Ademar B Lugão, Hassan Yousefnia, Clelia Dispenza, Siti Mohd Janib, Irfan U Khan, Michał Maurin, Piotr Ulański, Say Chye Joachim Loo, Agnes Safrany, Joao A Osso, Adriano Duatti, Kattesh V Katti
IAEA Contribution to Nanosized Targeted Radiopharmaceuticals for Drug Delivery. Pharmaceutics 14 (5) (2022)
Tamer M Sakr, Mohammed A Khedr, Hassan M Rashed, Maged Elsayed Mohamed
In Silico-Based Repositioning of Phosphinothricin as a Novel Technetium-99m Imaging Probe with Potential Anti-Cancer Activity. Molecules (Basel, Switzerland) 23 (2) (2018)

Tamer M Sakr.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tamer M Sakr